
Glow-on Scans Trim Unnecessary Prostate Biopsies
Australian researchers show that PSMA PET/CT scans light up aggressive prostate cancers so clearly that many patients with inconclusive MRI can avoid invasive biopsies, potentially halving biopsy rates without missing clinically significant disease; the Primary2 trial (about 660 men) found that those with negative scans did not need biopsies and those with positive scans had targeted biopsies, with two-year follow-up and increasing availability in Australia and Europe.













